The optimal timing of initiation and duration of DAPT: recent findings and their impact on future patient care

EBAC Accredited Educational Programme - Programme supported by an unrestricted educational grant from ASTRAZENECA

Summary

 

Learning Objectives

  • To appreciate roles of DAPT in reducing ongoing cardiovascular disease risk and in-stent protection in patients with ACS
  • To review the recent clinical data exploring the optimal time of initiation and duration of DAPT in patients with coronary artery disease undergoing PCI
  • To explore how DAPT can be tailored to the patient to improve outcomes

Presentations available when logged in:

  • Session objectives
  • What is the optimal time for DAPT initiation: P2Y12 inhibitor administration in the ambulance, emergency room or cathlab?
  • What is the optimal DAPT duration for patients with coronary artery disease undergoing PCI?
  • Tailoring DAPT to the benefit: risk profile of the patient
  • Session evaluation and key learnings